On the public citation graph
Biphasic Clearance Kinetics of Hepatitis B Virus From Patients During Adefovir Dipivoxil Therapy
0 signed · 259 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/hep.1840190219openalex-snapshot
Characterization of the antiviral effects of 2′ carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus
inferredcites →https://doi.org/10.1002/hep.510230225openalex-snapshot
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
inferredcites →https://doi.org/10.1002/hep.510260130openalex-snapshot
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
inferredcites →https://doi.org/10.1002/hep.510280132openalex-snapshot
Hepatitis C virus dynamics in vivo : Effect of ribavirin and interferon alfa on viral turnover
inferredcites →https://doi.org/10.1016/s0166-3542(87)80004-9openalex-snapshot
Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines
inferredcites →https://doi.org/10.1016/s0168-8278(05)80439-8openalex-snapshot
The problem of antiviral therapy for chronic hepadnavirus infections
inferredcites →https://doi.org/10.1016/s0168-8278(97)80104-3openalex-snapshot
Evolution of hepatitis C virus quasispecies in mothers and infants infected through mother-to-infant transmission
inferredcites →https://doi.org/10.1016/s0168-8278(97)80345-5openalex-snapshot
Dynamics of hepatitis B virus infection in vivo
inferredcites →https://doi.org/10.1021/js970264sopenalex-snapshot
Oral Formulations of Adefovir Dipivoxil: In Vitro Dissolution and in Vivo Bioavailability in Dogs
inferredcites →https://doi.org/10.1038/323464a0openalex-snapshot
A novel selective broad-spectrum anti-DNA virus agent
inferredcites →https://doi.org/10.1038/373117a0openalex-snapshot
Viral dynamics in human immunodeficiency virus type 1 infection
inferredcites →https://doi.org/10.1038/373123a0openalex-snapshot
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
inferredcites →https://doi.org/10.1056/nejm199512213332501openalex-snapshot
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
inferredcites →https://doi.org/10.1056/nejm199712113372406openalex-snapshot
Hepatitis B Virus Infection
inferredcites →https://doi.org/10.1056/nejm199807093390201openalex-snapshot
A One-Year Trial of Lamivudine for Chronic Hepatitis B
inferredcites →https://doi.org/10.1073/pnas.86.18.7059openalex-snapshot
Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences.
inferredcites →https://doi.org/10.1073/pnas.88.19.8495openalex-snapshot
Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.
inferredcites →https://doi.org/10.1073/pnas.93.13.6542openalex-snapshot
The dynamics of hepatitis B virus infection.
inferredcites →https://doi.org/10.1073/pnas.93.14.7247openalex-snapshot
Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay.
inferredcites →https://doi.org/10.1073/pnas.93.9.4398openalex-snapshot
Viral dynamics in hepatitis B virus infection.
inferredcites →https://doi.org/10.1073/pnas.94.13.6971openalex-snapshot
Virus dynamics and drug therapy
inferredcites →https://doi.org/10.1080/15257779408012151openalex-snapshot
Antiviral Activity Spectrum and Target of Action of Different Classes of Nucleoside Analogues
inferredcites →https://doi.org/10.1086/514057openalex-snapshot
Anti‐Human Immunodeficiency Virus (HIV) Activity, Safety, and Pharmacokinetics of Adefovir Dipivoxil (9‐[2‐(bis‐pivaloyloxymethyl)‐phosphonylmethoxyethyl]adenine) in HIV‐Infected Patients
inferredcites →https://doi.org/10.1086/514150openalex-snapshot
The Safety and Efficacy of Adefovir Dipivoxil, a Novel Anti‐Human Immunodeficiency Virus (HIV) Therapy, in HIV‐Infected Adults: A Randomized, Double‐Blind, Placebo‐Controlled Trial
inferredcites →https://doi.org/10.1111/j.1365-2893.1996.tb00098.xopenalex-snapshot
A double blind, placebo‐controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection
inferredcites →https://doi.org/10.1126/science.271.5255.1582openalex-snapshot
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
inferredcites →https://doi.org/10.1126/science.272.5258.74openalex-snapshot
Population Dynamics of Immune Responses to Persistent Viruses
inferredcites →https://doi.org/10.1126/science.282.5386.103openalex-snapshot
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
inferredcites →https://doi.org/10.1128/aac.32.7.1025openalex-snapshot
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents
inferredcites →https://doi.org/10.1128/aac.41.7.1444openalex-snapshot
Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus
inferredcites →https://doi.org/10.1128/jvi.71.10.7518-7525.1997openalex-snapshot
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection
inferredcites →https://doi.org/10.1128/jvi.71.4.3275-3278.1997openalex-snapshot
Human immunodeficiency virus drug therapy and virus load
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.5281/zenodo.1070109openalex-extracted
Controllability Of Efficiency Of Antiviral Therapy In Hepatitis B Virus Infections
inferred← citeshttps://doi.org/10.1002/0471238961.0114200918052201.a01.pub2openalex-snapshot
Antiviral Agents
inferred← citeshttps://doi.org/10.1002/hep.20374openalex-snapshot
A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection
inferred← citeshttps://doi.org/10.1002/hep.20738openalex-snapshot
A Viral Kinetic Study Using Pegylated Interferon Alfa-2b and/or Lamivudine in Patients With Chronic Hepatitis B/HBeAg Negative *
inferred← citeshttps://doi.org/10.1002/hep.21302openalex-snapshot
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response
inferred← citeshttps://doi.org/10.1002/hep.21364openalex-snapshot
The half-life of hepatitis B virions
inferred← citeshttps://doi.org/10.1002/hep.22586openalex-snapshot
Modeling complex decay profiles of hepatitis B virus during antiviral therapy†‡
inferred← citeshttps://doi.org/10.1002/hep.22658openalex-snapshot
Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B
inferred← citeshttps://doi.org/10.1002/hep.22754openalex-snapshot
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1–hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy #
inferred← citeshttps://doi.org/10.1002/hep.22918openalex-snapshot
Hepatitis B virus clearance rate estimates #
inferred← citeshttps://doi.org/10.1002/hep.23778openalex-snapshot
Novel Mechanism of Antibodies to Hepatitis B Virus in Blocking Viral Particle Release from Cells†
inferred← citeshttps://doi.org/10.1002/hep.26277openalex-snapshot
Efficacy of Tenofovir Disoproxil Fumarate At 240 Weeks in Patients With Chronic Hepatitis B With High Baseline Viral Load
inferred← citeshttps://doi.org/10.1002/jmv.10291openalex-snapshot
Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses
inferred← citeshttps://doi.org/10.1002/jmv.20822openalex-snapshot
Characterization of viral kinetics in patients with hepatitis B e antigen‐positive chronic hepatitis B
inferred← citeshttps://doi.org/10.1002/lt.20572openalex-snapshot
Kinetics of hepatitis C virus reinfection after liver transplantation
inferred← citeshttps://doi.org/10.1002/mma.8547openalex-snapshot
A delayed diffusive HBV model with nonlinear incidence and CTL immune response
inferred← citeshttps://doi.org/10.1002/psp4.13298openalex-snapshot
Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection
inferred← citeshttps://doi.org/10.1002/psp4.70172openalex-snapshot
A Quantitative Systems Pharmacology (QSP) Model of Acute Hepatitis B Virus Infection: Mechanistic Insights and Foundations for Future Extensions
inferred← citeshttps://doi.org/10.1002/rmv.373openalex-snapshot
HIV viral load: the myth of the undetectable?
inferred← citeshttps://doi.org/10.1002/rmv.393openalex-snapshot
Treatment of chronic hepatitis B: current challenges and future directions
inferred← citeshttps://doi.org/10.1002/sim.3457openalex-snapshot
Modelling of viral dynamics in hepatitis B and hepatitis C clinical trials
inferred← citeshttps://doi.org/10.1007/978-1-59259-104-6_7openalex-snapshot
Treatment of Chronic Hepatitis B
inferred← citeshttps://doi.org/10.1007/978-3-0348-7903-3_11openalex-snapshot
Problems inherent to antiviral therapy
inferred← citeshttps://doi.org/10.1007/978-3-0348-7903-3_9openalex-snapshot
Viral response to therapy: viral dynamics
inferred← citeshttps://doi.org/10.1007/978-3-211-49277-2_54openalex-snapshot
Recurrent Diseases after Liver Transplantation
inferred← citeshttps://doi.org/10.1007/978-90-481-2759-7_4openalex-snapshot
The hepatitis B virus — virology
inferred← citeshttps://doi.org/10.1007/s00285-023-01869-wopenalex-snapshot
Viral dynamics with immune responses: effects of distributed delays and Filippov antiretroviral therapy
inferred← citeshttps://doi.org/10.1007/s00521-012-1146-4openalex-snapshot
Antiviral therapy using a fuzzy controller optimized by modified evolutionary algorithms: a comparative study
inferred← citeshttps://doi.org/10.1007/s10620-011-1873-xopenalex-snapshot
High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-On
inferred← citeshttps://doi.org/10.1007/s11071-011-0022-6openalex-snapshot
The importance of immune responses in a model of hepatitis B virus
inferred← citeshttps://doi.org/10.1007/s11071-023-08580-xopenalex-snapshot
Stability and Hopf bifurcation on an immunity delayed HBV/HCV model with intra- and extra-hepatic coinfection and saturation incidence
inferred← citeshttps://doi.org/10.1007/s11538-025-01555-6openalex-snapshot
Investigation of a Two-Patch Within-Host Model of Hepatitis B Viral Infection
inferred← citeshttps://doi.org/10.1007/s11596-014-1312-2openalex-snapshot
Combination therapy with pegylated interferon alpha-2b and adefovir dipivoxil in HBeAg-positive chronic hepatitis B versus interferon alone: a prospective, randomized study
inferred← citeshttps://doi.org/10.1007/s11894-002-0039-6openalex-snapshot
How will we use the new antiviral agents for hepatitis B?
inferred← citeshttps://doi.org/10.1007/s11901-003-0022-1openalex-snapshot
Hepatitis B: Treatment strategies for currently available drugs
inferred← citeshttps://doi.org/10.1007/s11901-005-0023-3openalex-snapshot
Molecular virology and drug resistance in antiviral therapy of chronic hepatitis B
inferred← citeshttps://doi.org/10.1007/s11901-010-0054-2openalex-snapshot
HBV Drug Resistance Development, Testing, and Prevention
inferred← citeshttps://doi.org/10.1007/s12072-009-9149-7openalex-snapshot
The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B
inferred← citeshttps://doi.org/10.1016/b978-044450986-4/50071-0openalex-snapshot
Novel approaches in the management of chronic HBV infection
inferred← citeshttps://doi.org/10.1016/j.aej.2025.01.029openalex-snapshot
Co-dynamics of hepatitis B and C viruses under the influence of CTL immunity
inferred← citeshttps://doi.org/10.1016/j.antiviral.2004.07.003openalex-snapshot
Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infection
inferred← citeshttps://doi.org/10.1016/j.antiviral.2008.09.005openalex-snapshot
Serum HBsAg changes in HBeAg positive chronic hepatitis B patients with continuous viral load reductions during treatment with adefovir or peg-interferon-α-2a
inferred← citeshttps://doi.org/10.1016/j.antiviral.2013.01.006openalex-snapshot
Chronic hepatitis B: What should be the goal for new therapies?
inferred← citeshttps://doi.org/10.1016/j.bbrc.2006.01.166openalex-snapshot
A probability cellular automaton model for hepatitis B viral infections
inferred← citeshttps://doi.org/10.1016/j.cgh.2006.03.017openalex-snapshot
Chronic Hepatitis B: Current Testing Strategies
inferred← citeshttps://doi.org/10.1016/j.coisb.2019.10.003openalex-snapshot
Within-host mathematical models of hepatitis B virus infection: Past, present, and future
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2013.09.025openalex-snapshot
Modeling chronic hepatitis B or C virus infection during antiviral therapy using an analogy to enzyme kinetics: Long-term viral dynamics without rebound and oscillation
inferred← citeshttps://doi.org/10.1016/j.fraope.2025.100454openalex-snapshot
A mathematical exploration of HBV infection using fractional derivatives and the homotopy decomposition method
inferred← citeshttps://doi.org/10.1016/j.gtc.2004.04.008openalex-snapshot
Antiviral therapy for treatment-naıve hepatitis B virus patients
inferred← citeshttps://doi.org/10.1016/j.gtc.2006.03.002openalex-snapshot
Hepatitis B: The Pathway to Recovery Through Treatment
inferred← citeshttps://doi.org/10.1016/j.gtc.2006.10.002openalex-snapshot
Hepatitis B: The Pathway to Recovery Through Treatment
inferred← citeshttps://doi.org/10.1016/j.gtc.2010.08.012openalex-snapshot
New Pharmacologic Therapies in Chronic Hepatitis B
inferred← citeshttps://doi.org/10.1016/j.hep.2003.09.009openalex-snapshot
Inhibitory Effect of Adefovir and Lamivudine on the Initiation of Hepatitis B Virus Infection in Primary Tupaia Hepatocytes
inferred← citeshttps://doi.org/10.1016/j.ifacol.2015.11.007openalex-snapshot
A hybrid model for hepatitis B virus
inferred← citeshttps://doi.org/10.1016/j.jceh.2017.10.002openalex-snapshot
Ideal Cure for Hepatitis B Infection: The Target is in Sight
inferred← citeshttps://doi.org/10.1016/j.jcv.2005.12.004openalex-snapshot
Wild type and YMDD variant of hepatitis B virus: No difference in viral kinetics on lamivudine/tenofovir therapy in HIV–HBV co-infected patients
inferred← citeshttps://doi.org/10.1016/j.jhep.2004.12.015openalex-snapshot
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA
inferred← citeshttps://doi.org/10.1016/j.jhep.2005.02.037openalex-snapshot
Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir–lamivudine combination therapy
inferred← citeshttps://doi.org/10.1016/j.jhep.2005.05.011openalex-snapshot
Adefovir-lamivudine combination therapy and hepatitis B viral kinetics
inferred← citeshttps://doi.org/10.1016/j.jhep.2007.02.016openalex-snapshot
Tailoring antiviral therapy in chronic hepatitis B patients with lamivudine resistance
inferred← citeshttps://doi.org/10.1016/j.jhep.2025.02.002openalex-snapshot
Reply to: “Optimizing antiviral prophylaxis strategies: Insights and reflections on a real-world study” and “Optimal timing to initiate antiviral prophylaxis of MTCT: More needs to be done”
inferred← citeshttps://doi.org/10.1016/j.jtbi.2007.02.017openalex-snapshot
Modeling the mechanisms of acute hepatitis B virus infection
inferred← citeshttps://doi.org/10.1016/j.jtbi.2010.10.024openalex-snapshot
A mathematical model of the intracellular replication and within host evolution of hepatitis type B virus: Understanding the long time course of chronic hepatitis
inferred← citeshttps://doi.org/10.1016/j.jtbi.2011.05.013openalex-snapshot
Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin
inferred← citeshttps://doi.org/10.1016/j.jtbi.2015.12.005openalex-snapshot
Variability in long-term hepatitis B virus dynamics under antiviral therapy
inferred← citeshttps://doi.org/10.1016/j.jtbi.2016.02.008openalex-snapshot
The intracellular dynamics of hepatitis B virus (HBV) replication with reproduced virion “re-cycling”
inferred← citeshttps://doi.org/10.1016/j.jtbi.2016.03.038openalex-snapshot
Mathematical modeling and systems pharmacology of tuberculosis: Isoniazid as a case study
inferred← citeshttps://doi.org/10.1016/j.jviromet.2019.01.014openalex-snapshot
The review of differential equation models of HBV infection dynamics
inferred← citeshttps://doi.org/10.1016/j.mam.2007.09.015openalex-snapshot
Personalized therapy in chronic viral hepatitis
inferred← citeshttps://doi.org/10.1016/j.matcom.2023.04.034openalex-snapshot
Heuristic computing with sequential quadratic programming for solving a nonlinear hepatitis B virus model
inferred← citeshttps://doi.org/10.1016/j.mbs.2010.01.002openalex-snapshot
Influence of backward bifurcation in a model of hepatitis B and C viruses
inferred← citeshttps://doi.org/10.1016/j.mbs.2024.109302openalex-snapshot
Modeling virus-stimulated proliferation of CD4 + T-cell, cell-to-cell transmission and viral loss in HIV infection dynamics
inferred← citeshttps://doi.org/10.1016/j.physleta.2024.129985openalex-snapshot
Patient visit behaviour shapes the virus infection dynamics in hosts
inferred← citeshttps://doi.org/10.1016/j.trre.2004.03.002openalex-snapshot
Management of chronic hepatitis B in the liver transplant setting
inferred← citeshttps://doi.org/10.1016/j.virs.2023.12.005openalex-snapshot
Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics
inferred← citeshttps://doi.org/10.1016/s0016-5085(00)70008-4openalex-snapshot
Antiviral chemotherapy for the treatment of hepatitis b virus infections
inferred← citeshttps://doi.org/10.1016/s0025-5564(02)00099-8openalex-snapshot
Mathematical analysis of delay differential equation models of HIV-1 infection
inferred← citeshttps://doi.org/10.1016/s0149-2918(03)90093-2openalex-snapshot
Adefovir dipivoxil: A new antiviral agent for the treatment of hepatitis B virus infection
inferred← citeshttps://doi.org/10.1016/s0166-3542(01)00223-6openalex-snapshot
Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus
inferred← citeshttps://doi.org/10.1016/s0166-3542(02)00071-2openalex-snapshot
Hepatitis B treatment: rational combination chemotherapy based on viral kinetic and animal model studies
inferred← citeshttps://doi.org/10.1016/s0166-3542(99)00056-xopenalex-snapshot
Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies
inferred← citeshttps://doi.org/10.1016/s0168-8278(00)00074-xopenalex-snapshot
Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo
inferred← citeshttps://doi.org/10.1016/s0168-8278(00)80017-3openalex-snapshot
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels
inferred← citeshttps://doi.org/10.1016/s0168-8278(00)80418-3openalex-snapshot
Hepatitis B infection: Pathogenesis and management
inferred← citeshttps://doi.org/10.1016/s0168-8278(02)00113-7openalex-snapshot
The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine
inferred← citeshttps://doi.org/10.1016/s0168-8278(02)00115-0openalex-snapshot
Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B
inferred← citeshttps://doi.org/10.1016/s0168-8278(02)00210-6openalex-snapshot
Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase
inferred← citeshttps://doi.org/10.1016/s0168-8278(02)00425-7openalex-snapshot
Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model
inferred← citeshttps://doi.org/10.1016/s0168-8278(03)00076-xopenalex-snapshot
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders
inferred← citeshttps://doi.org/10.1016/s0168-8278(03)00136-3openalex-snapshot
Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics
inferred← citeshttps://doi.org/10.1016/s0168-8278(03)00318-0openalex-snapshot
Hepatitis B viral resistance: mechanisms and diagnosis
inferred← citeshttps://doi.org/10.1016/s0168-8278(03)00416-1openalex-snapshot
Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection
inferred← citeshttps://doi.org/10.1016/s0192-0561(00)00068-0openalex-snapshot
Macrophage activation by antiviral acyclic nucleoside phosphonates in dependence on priming immune stimuli
inferred← citeshttps://doi.org/10.1016/s0923-2532(01)80031-4openalex-snapshot
Nouveaux traitements de l'hépatite B et techniques d'étude de la résistance virale
inferred← citeshttps://doi.org/10.1016/s1089-3261(02)00063-6openalex-snapshot
Mathematical modeling of viral kinetics:
inferred← citeshttps://doi.org/10.1016/s1286-4579(02)01603-9openalex-snapshot
Dynamics of hepatitis B virus infection
inferred← citeshttps://doi.org/10.1016/s1386-6532(02)00018-5openalex-snapshot
Guidelines for laboratory monitoring of treatment of persistent virus infections
inferred← citeshttps://doi.org/10.1016/s1386-6532(05)80008-3openalex-snapshot
Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing
inferred← citeshttps://doi.org/10.1016/s1386-6532(05)80018-6openalex-snapshot
The competing roles of virus replication and hepatocyte death rates in the emergence of drug-resistant mutants: Theoretical considerations
inferred← citeshttps://doi.org/10.1016/s1473-3099(01)00118-9openalex-snapshot
Treatment of chronic hepatitis B
inferred← citeshttps://doi.org/10.1023/b:caco.0000007984.79987.ecopenalex-snapshot
Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population
inferred← citeshttps://doi.org/10.1034/j.1600-0676.2002.01579.xopenalex-snapshot
Viral dynamics in chronic hepatitis B patients during lamivudine therapy
inferred← citeshttps://doi.org/10.1038/emi.2014.64openalex-snapshot
Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance
inferred← citeshttps://doi.org/10.1038/mtna.2014.38openalex-snapshot
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
inferred← citeshttps://doi.org/10.1038/nri700openalex-snapshot
Modelling viral and immune system dynamics
inferred← citeshttps://doi.org/10.1046/j.0902-0063.2003.00097.xopenalex-snapshot
Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation
inferred← citeshttps://doi.org/10.1046/j.1365-2893.2003.00471.xopenalex-snapshot
Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy
inferred← citeshttps://doi.org/10.1046/j.1440-1746.17.s1.3.xopenalex-snapshot
Management of viral hepatitis B
inferred← citeshttps://doi.org/10.1053/gast.2001.24401openalex-snapshot
How can mathematics help us understand HCV?
inferred← citeshttps://doi.org/10.1053/gast.2002.37058openalex-snapshot
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection
inferred← citeshttps://doi.org/10.1053/gast.2002.37288openalex-snapshot
Chemotherapy for hepatitis B: New treatment options necessitate reappraisal of traditional endpoints
inferred← citeshttps://doi.org/10.1053/j.gastro.2004.03.018openalex-snapshot
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆
inferred← citeshttps://doi.org/10.1053/jhep.2000.16181openalex-snapshot
Combination chemotherapy for hepatitis B virus: The final solution?
inferred← citeshttps://doi.org/10.1053/jhep.2000.18194openalex-snapshot
The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B
inferred← citeshttps://doi.org/10.1053/jhep.2000.8701openalex-snapshot
Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir In vitro do not lead to reduction of the closed circular DNA
inferred← citeshttps://doi.org/10.1053/jhep.2000.9143openalex-snapshot
Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study
inferred← citeshttps://doi.org/10.1053/jhep.2001.28509openalex-snapshot
Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed
inferred← citeshttps://doi.org/10.1053/jhep.2003.50389openalex-snapshot
New Targets and Possible New Therapeutic Approaches in the Chemotherapy of Chronic Hepatitis B
inferred← citeshttps://doi.org/10.1054/drup.2001.0190openalex-snapshot
Lamivudine resistance in hepatitis B: mechanisms and clinical implications
inferred← citeshttps://doi.org/10.1063/5.0025235openalex-snapshot
Approximate solutions of viral dynamics in HBV infection using homotopy perturbation method
inferred← citeshttps://doi.org/10.1073/pnas.0603626104openalex-snapshot
The role of cells refractory to productive infection in acute hepatitis B viral dynamics
inferred← citeshttps://doi.org/10.1080/02664763.2014.885001openalex-snapshot
A refined parameter estimating approach for HIV dynamic model
inferred← citeshttps://doi.org/10.1080/17513758.2020.1859632openalex-snapshot
Threshold dynamics of a HCV model with virus to cell transmission in both liver with CTL immune response and the extrahepatic tissue
inferred← citeshttps://doi.org/10.1084/jem.193.7.847openalex-snapshot
Kinetics of Acute Hepatitis B Virus Infection in Humans
inferred← citeshttps://doi.org/10.1086/378739openalex-snapshot
Response to Lamivudine Treatment in Children with Chronic Hepatitis B Virus Infection
inferred← citeshttps://doi.org/10.1086/656528openalex-snapshot
Hepatitis B Virus Kinetics under Antiviral Therapy Sheds Light on Differences in Hepatitis B e Antigen Positive and Negative Infections
inferred← citeshttps://doi.org/10.1093/imammb/dqu022openalex-snapshot
Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach
inferred← citeshttps://doi.org/10.1093/jac/dkg163openalex-snapshot
Hepatitis B virus: old, new and future approaches to antiviral treatment
inferred← citeshttps://doi.org/10.1093/jac/dkn175openalex-snapshot
Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?
inferred← citeshttps://doi.org/10.1097/00002030-200006160-00007openalex-snapshot
Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study
inferred← citeshttps://doi.org/10.1097/00042737-200112000-00016openalex-snapshot
Nucleoside analogues for chronic hepatitis B
inferred← citeshttps://doi.org/10.1097/00042737-200209000-00012openalex-snapshot
Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine–famciclovir or lamivudine–ganciclovir
inferred← citeshttps://doi.org/10.1097/01.aids.0000171404.07995.5copenalex-snapshot
Long-term hepatitis B virus dynamics in HIV–hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate
inferred← citeshttps://doi.org/10.1097/01.aids.0000218550.85081.59openalex-snapshot
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
inferred← citeshttps://doi.org/10.1098/rsif.2016.0130openalex-snapshot
Estimating biologically relevant parameters under uncertainty for experimental within-host murine West Nile virus infection
inferred← citeshttps://doi.org/10.1101/cshperspect.a021386openalex-snapshot
Hepadnavirus Genome Replication and Persistence
inferred← citeshttps://doi.org/10.1109/iccis.2010.88openalex-snapshot
Identification and Simulation of Hepatitis B Virus Model
inferred← citeshttps://doi.org/10.1109/isb.2011.6033160openalex-snapshot
Dynamics of HBV model with intermittent antiviral therapy
inferred← citeshttps://doi.org/10.1111/apt.15890openalex-snapshot
Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg‐positive chronic hepatitis B treated with nucleos(t)ide analogues
inferred← citeshttps://doi.org/10.1111/imr.12686openalex-snapshot
Modeling the dynamics of hepatitis B infection, immunity, and drug therapy
inferred← citeshttps://doi.org/10.1111/j.1365-2893.2004.00523.xopenalex-snapshot
Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg vs 100 mg of lamivudine daily*
inferred← citeshttps://doi.org/10.1111/j.1365-2893.2005.00620.xopenalex-snapshot
Viral dynamics during tenofovir therapy in patients infected with lamivudine‐resistant hepatitis B virus mutants
inferred← citeshttps://doi.org/10.1111/j.1365-2893.2007.00954.xopenalex-snapshot
Modelling hepatitis C virus kinetics during treatment with pegylated interferon α‐2b: errors in the estimation of viral kinetic parameters
inferred← citeshttps://doi.org/10.1111/j.1440-1746.2004.03694.xopenalex-snapshot
New directions in molecular diagnostics for hepatitis B: serum and tissue‐based diagnostics
inferred← citeshttps://doi.org/10.1111/j.1440-1746.2008.05759.xopenalex-snapshot
Anti‐hepatitis B virus treatment guided by long‐term virus kinetics stepwise tracing
inferred← citeshttps://doi.org/10.1111/j.1872-034x.2007.00108.xopenalex-snapshot
Improving outcomes for patients with chronic hepatitis B
inferred← citeshttps://doi.org/10.1111/jvh.13425openalex-snapshot
What drives the dynamics of HBV RNA during treatment?
inferred← citeshttps://doi.org/10.1126/scitranslmed.3000544openalex-snapshot
Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
inferred← citeshttps://doi.org/10.1128/aac.00467-07openalex-snapshot
Hepatitis B Virus e Antigen Loss during Adefovir Dipivoxil Therapy Is Associated with Enhanced Virus-Specific CD4+T-Cell Reactivity
inferred← citeshttps://doi.org/10.1128/aac.01163-09openalex-snapshot
Early Viral Kinetics of Telbivudine and Entecavir: Results of a 12-Week Randomized Exploratory Study with Patients with HBeAg-Positive Chronic Hepatitis B
inferred← citeshttps://doi.org/10.1128/aac.46.2.425-433.2002openalex-snapshot
Inhibitory Effect of Adefovir on Viral DNA Synthesis and Covalently Closed Circular DNA Formation in Duck Hepatitis B Virus-Infected Hepatocytes In Vivo and In Vitro
inferred← citeshttps://doi.org/10.1128/aac.46.9.2872-2877.2002openalex-snapshot
Antiviral Activities of MCC-478, a Novel and Specific Inhibitor of Hepatitis B Virus
inferred← citeshttps://doi.org/10.1128/aac.47.6.1842-1852.2003openalex-snapshot
Effects of Pyrimidine and Purine Analog Combinations in the Duck Hepatitis B Virus Infection Model
inferred← citeshttps://doi.org/10.1128/jcm.43.2.596-603.2005openalex-snapshot
Evaluation of the COBAS Amplicor HBV Monitor Assay and Comparison with the Ultrasensitive HBV Hybrid Capture 2 Assay for Quantification of Hepatitis B Virus DNA
inferred← citeshttps://doi.org/10.1128/jvi.01623-05openalex-snapshot
Kinetics of Influenza A Virus Infection in Humans
inferred← citeshttps://doi.org/10.1128/jvi.02164-09openalex-snapshot
Distinct Hepatitis B Virus Dynamics in the Immunotolerant and Early Immunoclearance Phases
inferred← citeshttps://doi.org/10.1128/jvi.02415-06openalex-snapshot
The Level of Viral Antigen Presented by Hepatocytes Influences CD8 T-Cell Function
inferred← citeshttps://doi.org/10.1135/cccc20011545openalex-snapshot
Synthesis and Cytostatic Activity of N-[2-(Phosphonomethoxy)alkyl] Derivatives of N6-Substituted Adenines, 2,6-Diaminopurines and Related Compounds
inferred← citeshttps://doi.org/10.1136/gut.49.6.860openalex-snapshot
Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir
inferred← citeshttps://doi.org/10.1137/10079690xopenalex-snapshot
A Hepatitis B and C Virus Model with Age since Infection that Exhibits Backward Bifurcation
inferred← citeshttps://doi.org/10.1137/17m1134019openalex-snapshot
Early HIV Infection Predictions: Role of Viral Replication Errors
inferred← citeshttps://doi.org/10.1140/epjp/s13360-024-05604-2openalex-snapshot
Global analysis of HCV/HBV codynamics model with antibody immunity
inferred← citeshttps://doi.org/10.1142/s0218127415400118openalex-snapshot
Dynamics of an HBV Model with Drug Resistance Under Intermittent Antiviral Therapy
inferred← citeshttps://doi.org/10.1155/2013/712829openalex-snapshot
Hepatitis B Virus Dynamics: Modeling, Analysis, and Optimal Treatment Scheduling
inferred← citeshttps://doi.org/10.1155/jom/6616833openalex-snapshot
Unraveling the Complexities of Hepatitis B Virus Control: A Mathematical Modeling Approach
inferred← citeshttps://doi.org/10.1172/jci11100openalex-snapshot
The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance
inferred← citeshttps://doi.org/10.1172/jci13787openalex-snapshot
X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo
inferred← citeshttps://doi.org/10.1177/039139880102400906openalex-snapshot
Treatment of HBV-Related Liver Disease in the Dialysis Population: Reality and Promises
inferred← citeshttps://doi.org/10.1177/095632020101200101openalex-snapshot
Resistance of Hepatitis B Virus to Antiviral Drugs: Current Aspects and Directions for Future Investigation
inferred← citeshttps://doi.org/10.1177/095632020201300301openalex-snapshot
Review Hepatitis B Virus Resistance to Lamivudine and its Clinical Implications
inferred← citeshttps://doi.org/10.1177/095632020201300303openalex-snapshot
Viral Pharmacodynamic Model for (–)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine (Emtricitabine) in Chronically Infected Woodchucks
inferred← citeshttps://doi.org/10.1177/095632020401500602openalex-snapshot
Antiviral Therapy of Chronic Hepatitis B: Can We Clear the Virus and Prevent Drug Resistance?
inferred← citeshttps://doi.org/10.1177/135965350000500203openalex-snapshot
Hepatitis C Virus Kinetics
inferred← citeshttps://doi.org/10.1177/135965350601100201openalex-snapshot
A Multiphase Model of the Dynamics of HBV Infection in Hbeag-Negative Patients during Pegylated Interferon-α2A, Lamivudine and Combination Therapy
inferred← citeshttps://doi.org/10.1177/135965350601100704openalex-snapshot
One-Year Entecavir or Lamivudine Therapy Results in Reduction of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA Levels
inferred← citeshttps://doi.org/10.1177/135965350601100806openalex-snapshot
A Randomized Placebo-Controlled, Dose-Finding Study of Oral Lb80380 in Hbeag-Positive Patients with Chronic Hepatitis B
inferred← citeshttps://doi.org/10.1177/135965350701200513openalex-snapshot
Impact of Early Viral Kinetics on T-Cell Reactivity during Antiviral Therapy in Chronic Hepatitis B
inferred← citeshttps://doi.org/10.1177/135965350701200804openalex-snapshot
Modelling of Early Viral Kinetics and Pegylated Interferon-α2b Pharmacokinetics in Patients with HBeAg-Positive Chronic Hepatitis B
inferred← citeshttps://doi.org/10.1177/135965350801300106openalex-snapshot
Sequential Combination Therapy Leads to Biochemical and Histological Improvement Despite Low Ongoing Intrahepatic Hepatitis B virus Replication
inferred← citeshttps://doi.org/10.1177/135965350801300812openalex-snapshot
Virodynamic Predictors of Response to Pegylated Interferon and Lamivudine Combination Treatment of Hepatitis B e Antigen-Positive Chronic Hepatitis B
inferred← citeshttps://doi.org/10.1177/1756283x08093944openalex-snapshot
Review: Current status of antiviral therapy for hepatitis B
inferred← citeshttps://doi.org/10.1185/030079905x65268openalex-snapshot
A review of entecavir in the treatment of chronic hepatitis B infection
inferred← citeshttps://doi.org/10.1258/0956462011923930openalex-snapshot
European guideline for the management of hepatitis B and C virus infections
inferred← citeshttps://doi.org/10.1345/aph.1g027openalex-snapshot
Telbivudine: A Novel Nucleoside Analog for Chronic Hepatitis B
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1003730openalex-snapshot
Antibody Responses during Hepatitis B Viral Infection
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1003769openalex-snapshot
A Hepatitis C Virus Infection Model with Time-Varying Drug Effectiveness: Solution and Analysis
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1012322openalex-snapshot
A multiscale model of the action of a capsid assembly modulator for the treatment of chronic hepatitis B
inferred← citeshttps://doi.org/10.1371/journal.pone.0012512openalex-snapshot
Development of Mathematical Models for the Analysis of Hepatitis Delta Virus Viral Dynamics
inferred← citeshttps://doi.org/10.1371/journal.pone.0039591openalex-snapshot
Mathematical Models of E-Antigen Mediated Immune Tolerance and Activation following Prenatal HBV Infection
inferred← citeshttps://doi.org/10.1371/journal.pone.0050377openalex-snapshot
Mathematical Modeling of Triphasic Viral Dynamics in Patients with HBeAg-Positive Chronic Hepatitis B Showing Response to 24-Week Clevudine Therapy
inferred← citeshttps://doi.org/10.1371/journal.pone.0180756openalex-snapshot
Estimating mono- and bi-phasic regression parameters using a mixture piecewise linear Bayesian hierarchical model
inferred← citeshttps://doi.org/10.1371/journal.ppat.1010474openalex-snapshot
Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream
inferred← citeshttps://doi.org/10.1385/1-59259-670-3:361openalex-snapshot
Analysis of Hepatitis B Virus Dynamics and Its Impact on Antiviral Development
inferred← citeshttps://doi.org/10.1385/1-59259-670-3:457openalex-snapshot
Specific Considerations in the Design of Hepatitis B Virus Clinical Studies in the Far East
inferred← citeshttps://doi.org/10.1517/13543784.11.2.169openalex-snapshot
Evolving therapies for the treatment of chronic hepatitis B virus infection
showing the first 200 of 227 · page through all 227
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.